Preferences and Stated Adherence for Antibiotic Treatment of Cystic Fibrosis Pseudomonas Infections

被引:0
|
作者
Ateesha Farah Mohamed
F. Reed Johnson
Maria-Magdalena Balp
Frederico Calado
机构
[1] RTI-Health Solutions,Center for Clinical and Genetic Economics
[2] Novartis Pharma AG,undefined
[3] Duke Clinical Research Institute,undefined
[4] Duke University,undefined
关键词
Cystic Fibrosis; Cystic Fibrosis Patient; Preference Weight; Cystic Fibrosis Foundation; Independence From Irrelevant Alternative;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:59 / 67
页数:8
相关论文
共 50 条
  • [1] Preferences and Stated Adherence for Antibiotic Treatment of Cystic Fibrosis Pseudomonas Infections
    Mohamed, Ateesha Farah
    Johnson, F. Reed
    Balp, Maria-Magdalena
    Calado, Frederico
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2016, 9 (01): : 59 - 67
  • [2] CONVENIENCE AND STATED ADHERENCE FOR ANTIBIOTIC TREATMENT OF CYSTIC FIBROSIS PSEUDOMONAS INFECTIONS
    Mohamed, A. F.
    Johnson, R.
    Balp, M.
    Calado, F.
    PEDIATRIC PULMONOLOGY, 2013, 48 : 432 - 432
  • [3] Antibiotic choice for Pseudomonas pulmonary infections in children with cystic fibrosis
    Bingen, E
    PEDIATRIC PULMONOLOGY, 1997, : 45 - 45
  • [4] Adherence To The Inhaled Antibiotic Treatment In Patients With Cystic Fibrosis
    Sole, A.
    Gartner, S.
    Alvarez, A.
    Pastor, M.
    Baranda, F.
    Giron, R.
    Martinez, M.
    Prados, C.
    Maiz, L.
    Oliva, C.
    Gonzalez, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [5] Novel inhaled combined antibiotic formulations in the treatment of Pseudomonas aeruginosa airways infections in cystic fibrosis
    Antoniu, Sabina
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2015, 13 (07) : 897 - 905
  • [6] Antibiotic treatment of bacterial lung infections in cystic fibrosis
    Taccetti, Giovanni
    Terlizzi, Vito
    Campana, Silvia
    Dolce, Daniela
    Ravenni, Novella
    Fevola, Cristina
    Francalanci, Michela
    Galici, Valeria
    Neri, Anna Silvia
    EUROPEAN JOURNAL OF PEDIATRICS, 2024, 184 (01)
  • [7] STATED TIME-ALLOCATION, ADHERENCE, AND HEALTH-OUTCOME TRADEOFF PREFERENCES IN CYSTIC FIBROSIS HOUSEHOLDS
    Mohamed, A. F.
    Johnson, F. R.
    Gonzalez, J. M.
    Balp, M. M.
    VALUE IN HEALTH, 2013, 16 (03) : A26 - A26
  • [8] Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
    Hoiby, Niels
    BMC MEDICINE, 2011, 9
  • [9] ALTERNATIVE ANTIBIOTICS FOR THE TREATMENT OF PSEUDOMONAS INFECTIONS IN CYSTIC-FIBROSIS
    MASTELLA, G
    AGOSTINI, M
    BARLOCCO, G
    BONOMI, U
    BORGO, G
    BOZZINO, L
    CABRINI, G
    CAPPELLETTI, LM
    CASTELLANI, L
    CONFORTI, M
    MARAZZANI, S
    MARTINI, N
    MONTEMEZZI, P
    PAULON, G
    PEDERZINI, F
    SANCASSANI, L
    SCROCCARO, G
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 12 : 297 - 311
  • [10] Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
    Hurley, Matthew N.
    Camara, Miguel
    Smyth, Alan R.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40 (04) : 1014 - 1023